Chapter 30: Double-Stranded RNA Viruses: Reoviridae

Loading audio…

ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.

If there is an issue with this chapter, please let us know → Contact Us

Double-Stranded RNA Viruses: Reoviridae educational overview explores the Reoviridae family, with a primary focus on Rotavirus, a significant cause of severe gastroenteritis in infants and young children worldwide. These viruses are characterized by a unique structure consisting of non-enveloped, icosahedral particles containing a segmented double-stranded RNA genome. Under electron microscopy, Rotaviruses exhibit a distinctive appearance resembling a wheel with radiating spokes, featuring channels that facilitate the transport of materials for viral transcription. The replication process occurs entirely within the host cell's cytoplasm, where the virus undergoes partial uncoating and utilizes its own enzymes to synthesize and package new genomic segments. Because the genome is divided into eleven distinct parts, genetic reassortment can occur if a single cell is co-infected by different strains, potentially leading to new viral variants. Pathologically, the virus targets the epithelial cells of the small intestine, specifically the jejunum, causing significant damage to the intestinal villi. This destruction leads to a decrease in digestive enzymes like disaccharidases, resulting in a malabsorptive state where unabsorbed nutrients create a hyperosmotic effect, pulling water into the gut and causing profuse watery diarrhea. While the condition is often manageable with aggressive fluid and electrolyte replacement, it remains a leading cause of mortality in regions with limited medical resources. Diagnosis is typically achieved by identifying viral antigens in stool samples through laboratory assays. Prevention efforts rely heavily on improved sanitation and the administration of live-attenuated oral vaccines, which have proven effective in reducing the incidence of severe clinical outcomes.